ConductScience.org, home

Paper39593151

Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations.

Sayaf AM and 8 others. BMC Chem, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations. Papers, record 39593151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39593151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4- hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations.
PubMed
Journal
BMC Chem
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.56, provisional
iCite
Revised in PubMed
2024-11-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sayaf AMAbrar Mohammad
2Kousar KKafila
3Suleman MMuhammad
4Albekairi NANorah A
5Alshammari AAbdulRahman
6Mohammad AAnwar
7Khan AAbbas
8Agouni AAbdelali
9Yeoh KKKar Kheng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123721660HIM-herbal ingredients in-vivo metabolism database.J Cheminform2013https://conductscience.org/library/papers/23721660PubMed
229522307Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.ACS Chem Neurosci2018https://conductscience.org/library/papers/29522307PubMed
330682255Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.J Med Chem2019https://conductscience.org/library/papers/30682255PubMed
428928122Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia.J Pharmacol Exp Ther2017https://conductscience.org/library/papers/28928122PubMed
529532755Homocysteine and Hyperhomocysteinaemia.Curr Med Chem2019https://conductscience.org/library/papers/29532755PubMed
623937437Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.Annu Rev Pathol2014https://conductscience.org/library/papers/23937437PubMed
731628888Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy.Chem Biol Drug Des2020https://conductscience.org/library/papers/31628888PubMed
826610437Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.Molecules2015https://conductscience.org/library/papers/26610437PubMed
935498092Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity.RSC Adv2021https://conductscience.org/library/papers/35498092PubMed
1026656456HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.Nat Rev Nephrol2016https://conductscience.org/library/papers/26656456PubMed
1130849371VEGF in Signaling and Disease: Beyond Discovery and Development.Cell2019https://conductscience.org/library/papers/30849371PubMed
1216200636The Amber biomolecular simulation programs.J Comput Chem2005https://conductscience.org/library/papers/16200636PubMed
1335926869Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia.J Pharmacol Exp Ther2022https://conductscience.org/library/papers/35926869PubMed
1433431011Review on natural products databases: where to find data in 2020.J Cheminform2020https://conductscience.org/library/papers/33431011PubMed
1524205103AfroDb: a select highly potent and diverse natural product library from African medicinal plants.PLoS One2013https://conductscience.org/library/papers/24205103PubMed
1636450832Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5.Sci Rep2022https://conductscience.org/library/papers/36450832PubMed
1724575966Predictive in silico off-target profiling in drug discovery.Future Med Chem2014https://conductscience.org/library/papers/24575966PubMed
1835865575Design and synthesis of hybrid compounds as novel drugs and medicines.RSC Adv2022https://conductscience.org/library/papers/35865575PubMed
1921372172
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.
Mol Pharmacol2011https://conductscience.org/library/papers/21372172PubMed
2021905107The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling.Proteins2011https://conductscience.org/library/papers/21905107PubMed

See all 53 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42277171A tri-target in silico analysis of Testolift: a nutraceutical formulation targeting aromatase, myostatin, and prolyl hydroxylase-2 in testosterone regulation and muscle performance.Sci Rep2026https://conductscience.org/library/papers/42277171PubMed
41065364Molecular screening of natural compounds targeting KRAS(G12C): a multi-parametric strategy against acute lymphoblastic leukemia.J Enzyme Inhib Med Chem2025https://conductscience.org/library/papers/41065364PubMed
40872535Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872535PubMed
40552160Structure-based molecular screening and dynamic simulation of phytocompounds targeting VEGFR-2: a novel therapeutic approach for papillary thyroid carcinoma.Front Pharmacol2025https://conductscience.org/library/papers/40552160PubMed
40430547Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430547PubMed
40122680Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets.J Biomed Res2025https://conductscience.org/library/papers/40122680PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGLN154583PubTator's text mininghttps://conductscience.org/library/genes/54583NCBI Gene
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39593151

GET https://conductscience.org/api/papers/v1/39593151/references?page=2